Saturday, April 25, 2020

Healthcare Global Enterprises Ltd (HCG ) – Will it get benefited from COVID 19

Healthcare Global Enterprises Ltd (HCG )   closes   at  70.20   with  a  Loss     of    - 1.90 %   on    25-April-2020   with formation of  a  RED Candle    on Daily  Price Chart.
Why On Focus: Healthcare Global Enterprises Ltd (HCG ) has received permission from Drug Controller General of India to study the effectiveness of Plasma therapy to improve the conditions of seriously ill  Covid-19 patients & it has started trails on 10 patients & expected to complete the investigations in next our weeks.
Valuations :  Healthcare Global Enterprises Ltd (HCG ) has posted a loss of Rs. 25 Cr in FY2019 and it will  widen to Rs.68.9Cr in FY20 and seen reductions in Losses to Rs.55.5Cr in FY21 & Rs.24.9Cr in FY22.
Since it’s a loss making company, we express our inability to Value the Healthcare Global Enterprises Ltd (HCG ), since our proprietary model values only Profit making Companies.
Disclaimer : We are / may going to take exposure shortly.
Join Us at   Telegram #
Data Source | NSE Website | Screener.In  | Capital Line | Money Control |
The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

No comments:

Post a Comment

Thanks for Your Valuable comments. It will make Us to Serve You in Better Way. For Any STOCKS Query ,Please Call NiftyNext +91 880 2230 836.


The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.

Blog Archive